Mycobacterial immunotherapy for prostate cancer: where can we go from here?
NATURE REVIEWS UROLOGY(2020)
摘要
The effects of mycobacteria in prostate cancer have not been fully elucidated. Results of early studies indicated that mycobacterial immunotherapy conferred a survival benefit in patients with advanced prostate cancer, and recent evidence supports the safety and efficacy of new mycobacterial agents in many malignancies; thus, modern, carefully designed, randomized controlled trials of mycobacterial immunotherapy for prostate cancer could be warranted.
更多查看译文
关键词
Cancer immunotherapy,Prostate cancer,Medicine/Public Health,general,Urology
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要